Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren's syndrome.
Verstappen GM, de Wolff L, Arends S, Heiermann HM, van Sleen Y, Visser A, Terpstra JH, Diavatopoulos DA, van der Heiden M, Vissink A, van Baarle D, Kroese FGM, Bootsma H.
Verstappen GM, et al. Among authors: terpstra jh.
RMD Open. 2022 Apr;8(1):e002265. doi: 10.1136/rmdopen-2022-002265.
RMD Open. 2022.
PMID: 35414631
Free PMC article.